期刊文献+

亚临床甲状腺功能紊乱的研究进展 被引量:8

暂未订购
导出
摘要 自20世纪70年代以来,随着甲状腺功能检测方法的进展和就诊意识的提高,发现部分人群血清游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)正常,而血清促甲状腺激素(TSH)低于正常或轻度升高,临床表现不明显或不特异,称之为亚临床甲状腺功能紊乱。美国内分泌学术界曾于2002-09就亚临床甲状腺疾病的相关问题达成一定共识.包括亚临床甲状腺疾病的定义,流行病学情况,不治疗的后果,治疗的益处和风险,以及对高危人群进行亚临床甲状腺疾病的筛选。近年来,亚临床甲状腺疾病的潜在危害已被许多研究证实,因此受到更多的关注,老年人亚临床甲状腺疾病发病率高,临床表现不典型,易被忽略或误诊,从而对机体造成不良影响。亚临床甲状腺疾病包括亚临床甲状腺功能亢进症(SH)和亚临床甲状腺功能减退症(SHT),下面分别予以综述。
作者 王霜 杨正国
机构地区 [
出处 《实用医药杂志》 2008年第9期1129-1131,共3页 Practical Journal of Medicine & Pharmacy
  • 相关文献

参考文献21

  • 1Surks MI, Ortiz E ,Daniels GH, t al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 2004,291(2):228.
  • 2Biondi B, Palmieri EA, Klain M, et al. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol, 2005,152(1):1.
  • 3Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol, 2005,187(1):1.
  • 4Pinchera A. Subclinical thyroid disease: to treat or not to treat? Thyroid, 2005,15( 1 ):1.
  • 5Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adult. JAMA, 2006,295 (6):1033.
  • 6Smit JW, Eustatia-Rutten CF, Corssmit EP, et al. Reversible diastolic dysfunction afterlong-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab, 2005,90(12):6041.
  • 7Kvetny B. Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state. Exp Clin Endocrinol Diabetes, 2005,113(1):122.
  • 8Sheppard MG, Holder R, Franklyn JA. Levothyroxine treatment and occurrence of fracture of the hip. Arch Int Med, 2002,162 (2):338.
  • 9Sgarbi JA, antithyroid on clinical Villaca FG, Garbeline B, et al. The effects of early therapy for endogenous subclinical hyperthyroidism and heart abnormalities. J Clin Endocrinol Metab 2003,88(11):1672
  • 10Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA, 2005,294(1):71.

同被引文献56

  • 1刘超,蒋须勤.甲状腺功能异常对骨代谢的影响[J].江苏医药,1995,21(6):389-390. 被引量:3
  • 2沈群,李永琴.甲减、亚临床甲减和高脂血症的关系[J].江西医学院学报,2005,45(4):132-133. 被引量:14
  • 3冯雨,刘超.甲状腺功能异常对血脂代谢的影响[J].医学综述,2007,13(16):1237-1239. 被引量:17
  • 4Bindels AJ, Westendorp RG, Frolich M, et al. The prevalence of sub clinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for casefinding[J]. J Clin Endoerinol (Dxf),1999,50(2):217 -220.
  • 5Duntas LH. Thyroid disease and lipid[J]. Thyroid, 2002,12 (4): 287- 293.
  • 6Canaris GL, Manowitz NH, Mayor GM, et al. The Colorado thy- roid disease prevalence study[J]. Arch Intern Med, 2000,160(2): 526.
  • 7Sasaki S, Kawai K, Honjo Y, et al. Thyroid hormones and lipid metabolism[J]. Nippon Rinsho, 2006,64(12) : 2323-2329.
  • 8Saacs A,Aulchenko YS, Hofman A,et al. Epistatic effect of cholesteryl ester transferprotein and hepatic lipase on serum HDL 2C levels[J]. J Clin Endoerinol Metab, 2007,92(17) : 2680-2687.
  • 9(美)Lavin,N,姬伙和,张世俊,等.内分泌学及代谢疾病诊治手册[M].4版.北京:人民军医出版社,2012:469.
  • 10刘娇艳,魏军平,杨洪军.甲状腺疾病中西医结合治疗学[M].北京:科学技术文献出版社,2012:137.

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部